Edition:
United Kingdom

People: Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

31.58USD
6:20pm BST
Change (% chg)

$-0.28 (-0.88%)
Prev Close
$31.86
Open
$31.65
Day's High
$32.03
Day's Low
$30.75
Volume
45,335
Avg. Vol
168,840
52-wk High
$54.45
52-wk Low
$27.85

Porter, Derrell 

Dr.Derrell D. Porter, M.D. has served as our SVP, Head of Commercial since May 2017. From April 2013 to May 2017, he served as Vice President & Head, Commercial Planning at Gilead. From 2007 to 2013, he served in various roles at Abbvie including VP, Oncology Global Pipeline Marketing, Commercial Lead, HIV/Oncology International Marketing and VP/General Manager, Renal Care. Prior to that, he served in various roles at Amgen and was an Engagement Manager at McKinsey & Company. He received a B.S. from University of California, Los Angeles, an M.D. from University of Pennsylvania and a M.B.A from The Wharton School.

Basic Compensation

Total Annual Compensation, USD 457,457
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 1,052,940
Fiscal Year Total, USD 1,510,390

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Isaac Ciechanover

3,366,820

Utpal Koppikar

--

Joseph Newell

1,641,820

Christopher Haqq

3,298,020

Mitchall Clark

1,402,910

Gad Soffer

3,098,040
As Of  31 Dec 2017